An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer with KRAS ...
That is the finding of an observational study reported at the American Society of Haematology (ASH) congress, which focused on allogeneic or donor HSCTs used as a potentially curative treatment for ...
Integration agreement secured with Beth Israel Deaconess Medical Center, Boston USA Integration follows successful trial of ...
In 2022, the U.S. Congress enacted the Inflation Reduction Act (IRA), a landmark piece of legislation aimed at addressing various national priorities, including the reduction of prescription drug ...
Collaboration to evaluate monoclonal antibody as first-in-class treatment in this settingREDWOOD CITY, Calif. and HOUSTON, ...
Now one year on, the Alliance is home to over 140 organizations with 93 active projects bringing the benefits of open source ...
From powerful, data-driven insights and strategic consultancy support to agenda-setting events and hiring solutions, our products and services enable everyone in higher education to make smarter, more ...
Tempus AI leverages AI for precision medicine, offering genomics, data services, and AI applications. Click here to read an ...
Immutep (ASX:IMM) has announced the initiation of its TACTI-004 Phase III clinical trial, which aims to evaluate the efficacy ...
Perpetual (ASX:PPT) has provided an update on its proposed scheme of arrangement with KKR, revealing that tax complications ...
Covering Saudi Arabia’s markets, the report includes: It encompasses a robust vendor analysis tailored to assist clients in enhancing their market positioning. Specifically, the report furnishes a ...